Barclays’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
88,108
+41,032
| +87% | +$272K | ﹤0.01% | 2967 |
|
|
2025
Q1 | $431K | Sell |
47,076
-19,261
| -29% | -$176K | ﹤0.01% | 2922 |
|
|
2024
Q4 | $696K | Buy |
66,337
+15,683
| +31% | +$165K | ﹤0.01% | 2860 |
|
|
2024
Q3 | $606K | Buy |
50,654
+9,854
| +24% | +$118K | ﹤0.01% | 2879 |
|
|
2024
Q2 | $235K | Buy |
40,800
+6,498
| +19% | +$37.4K | ﹤0.01% | 2966 |
|
|
2024
Q1 | $178K | Sell |
34,302
-25,290
| -42% | -$131K | ﹤0.01% | 3397 |
|
|
2023
Q4 | $314K | Buy |
59,592
+23,522
| +65% | +$124K | ﹤0.01% | 3275 |
|
|
2023
Q3 | $119K | Buy |
+36,070
| New | +$119K | ﹤0.01% | 3260 |
|
|
2023
Q2 | – | Sell |
-18,524
| Closed | -$20K | – | 4259 |
|
|
2023
Q1 | $20K | Buy |
18,524
+9,945
| +116% | +$10.7K | ﹤0.01% | 3994 |
|
|
2022
Q4 | $22K | Buy |
8,579
+7,239
| +540% | +$18.6K | ﹤0.01% | 4002 |
|
|
2022
Q3 | $9K | Sell |
1,340
-246
| -16% | -$1.65K | ﹤0.01% | 4217 |
|
|
2022
Q2 | $11K | Sell |
1,586
-2,967
| -65% | -$20.6K | ﹤0.01% | 4282 |
|
|
2022
Q1 | $65K | Sell |
4,553
-29,475
| -87% | -$421K | ﹤0.01% | 3880 |
|
|
2021
Q4 | $493K | Buy |
34,028
+27,465
| +418% | +$398K | ﹤0.01% | 2535 |
|
|
2021
Q3 | $93K | Buy |
6,563
+5,510
| +523% | +$78.1K | ﹤0.01% | 3242 |
|
|
2021
Q2 | $19K | Sell |
1,053
-6,509
| -86% | -$117K | ﹤0.01% | 3730 |
|
|
2021
Q1 | $116K | Buy |
+7,562
| New | +$116K | ﹤0.01% | 3321 |
|